Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.21.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

    Three Months Ended March 31,  
    2021     2020  
Options to purchase common stock     1,845,282       998,814  
Restricted Stock Unvested     1,244,503        
Series H-1, H-3, H-4, H-5, I, J, pre-merger AYRO Merger common stock purchase warrants and post-merger AYRO warrants issued     7,361,083       461,647  
Series H, H-3, H-6, and pre-merger AYRO Seed Preferred Stock     2,475       2,007,193  
Totals     10,453,343       3,467,654